Wedbush Upgrades Alere (ALR) to Outperform; FDA Progress - Ability to Supply Market Improves
Tweet
Share
E-mailGet Alerts ALR Hot Sheet
Price: $1.32 --0%
Rating Summary:
6 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
6 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Wedbush upgraded Alere (NYSE: ALR) from Neutral to Outperform with a price target of $23.00.
Analyst, Zarak Khurshid, said, "ALR released an 8-k yesterday morning outlining details for the expected recall of product manufactured during 2011 and 1Q12. About 58% of the 803,000 tests recalled relate to cardiac panel tests (worth ~$20 MM in 1Q12)...Significant product return unlikely, given customer inventory turnover and recall language...More favorable product standard is helping ALR effectively supply the market and manage customer expectations...Shares of ALR are off 18% - Risk-reward interesting again."
For an analyst ratings summary and ratings history on Alere click here. For more ratings news on Alere click here.
Shares of Alere closed at $18.32 yesterday.
Analyst, Zarak Khurshid, said, "ALR released an 8-k yesterday morning outlining details for the expected recall of product manufactured during 2011 and 1Q12. About 58% of the 803,000 tests recalled relate to cardiac panel tests (worth ~$20 MM in 1Q12)...Significant product return unlikely, given customer inventory turnover and recall language...More favorable product standard is helping ALR effectively supply the market and manage customer expectations...Shares of ALR are off 18% - Risk-reward interesting again."
For an analyst ratings summary and ratings history on Alere click here. For more ratings news on Alere click here.
Shares of Alere closed at $18.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Bank of America (BAC) to Outperform, 'Underearning Firms Shouldn’t Trade at a Discount'
- Redburn-Atlantic Upgrades Shift4 Payments (FOUR) to Neutral Citing Balanced Risk/Reward Offering
- Morgan Stanley Upgrades Shopify (SHOP) to Overweight, 'Still Operating Leverage Left to Realize'
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
